Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
Sábháilte in:
Príomhchruthaitheoir: | Oza Manisha |
---|---|
Formáid: | Tráchtas LEABHAR |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
Mumbai
NMIMS-SPPSPTM
2019
|
Ábhair: | |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
de réir: Laddha Ankit P.
Foilsithe / Cruthaithe: (2021) -
Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
de réir: Suryavanshi Sachin Vilas
Foilsithe / Cruthaithe: (2021) -
Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
de réir: Parkar Nishad
Foilsithe / Cruthaithe: (2014) -
Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications
de réir: Adki Kaveri M.
Foilsithe / Cruthaithe: (2023) -
Therapeutic Potential of Beta-Caryophyllene Combined with L-Arginine in the Management of Diabetic Complications
de réir: Kumawat Vivek S.
Foilsithe / Cruthaithe: (2023)